During the period of factor Xa inhibitor discontinuation following ICH onset, thromboembolic events occurred in 3 patients (4.4%), comprising one case each of pulmonary embolism, myocardial infarction, and cerebral venous sinus thrombosis. The gene discussed is F10; the disease is myocardial infarction.